Guerbet's Elucirem™ Approved for Pediatric MRI with Half-Dose Gadolinium Use Guerbet's Elucirem™ (gadopiclenol) receives FDA approval for pediatric MRI use, including term neonates, with half the conventional gadolinium dosage.

Guerbet's Elucirem™ Approved for Pediatric MRI with Half-Dose Gadolinium Use #USA #Princeton #gadopiclenol #Guerbet #Elucirem

New Indication for Pediatric Use of Guerbet's Elucirem™ Approved by EU Commission Guerbet's Elucirem™ receives European Commission approval for pediatric MRI use, offering a reduced gadolinium dose for infants. A significant advancement in medical imaging.

New Indication for Pediatric Use of Guerbet's Elucirem™ Approved by EU Commission #France #gadopiclenol #Guerbet #Villepinte #Elucirem